5Heathcote EJ.Management of primary biliary cirrhosis:the American Association for the study of liver diseases practice guidelines[J].Hepatology,2000,31:1005-1013. 被引量：1
6Kaplan MM,Bonder A,Ruthazer R,et al.Methotrexate in patients with primary biliary cirrhosis who respond incompletely to treatment with ursodeoxychoIic acid[J].Dig Dis Sci,2010,55(11):3207-3217. 被引量：1
7Angulo P,Jorgensen RA,Keach JC,et al.Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid[J].Hepatology,2000,31:318-323. 被引量：1
8Han XF,Wang QX,Liu Y,et al.Efficacy of fenofibrate in Chinese patients with primary biliary cirrhosis partially responding to ursodeoxycholic acid therapy[J].J Dig Dis,2012,13(4):219-224. 被引量：1
9Lindor KD.Farnesoid X receptor agonists for primary biliary cirrhosis[J].Curr Opin Gastroenterol,2011,27(3):285-288. 被引量：1
10Tsuda M,Moritoki Y,Lian ZX,et al.Biochemical and immunologic effects of rituximab in patients with primary billary cirrhosis and an incomplete response to ursodeoxycholic acid[J].Hepatology,2012,55(2):512-521. 被引量：1
